7-78489792-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_012301.4(MAGI2):​c.1014G>A​(p.Lys338Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.305 in 1,610,112 control chromosomes in the GnomAD database, including 76,886 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.33 ( 8564 hom., cov: 32)
Exomes 𝑓: 0.30 ( 68322 hom. )

Consequence

MAGI2
NM_012301.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.67

Publications

19 publications found
Variant links:
Genes affected
MAGI2 (HGNC:18957): (membrane associated guanylate kinase, WW and PDZ domain containing 2) The protein encoded by this gene interacts with atrophin-1. Atrophin-1 contains a polyglutamine repeat, expansion of which is responsible for dentatorubral and pallidoluysian atrophy. This encoded protein is characterized by two WW domains, a guanylate kinase-like domain, and multiple PDZ domains. It has structural similarity to the membrane-associated guanylate kinase homologue (MAGUK) family. [provided by RefSeq, Jul 2008]
MAGI2 Gene-Disease associations (from GenCC):
  • nephrotic syndrome 15
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • familial idiopathic steroid-resistant nephrotic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • epilepsy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant 7-78489792-C-T is Benign according to our data. Variant chr7-78489792-C-T is described in ClinVar as Benign. ClinVar VariationId is 129557.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.67 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.422 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MAGI2NM_012301.4 linkc.1014G>A p.Lys338Lys synonymous_variant Exon 6 of 22 ENST00000354212.9 NP_036433.2 Q86UL8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MAGI2ENST00000354212.9 linkc.1014G>A p.Lys338Lys synonymous_variant Exon 6 of 22 1 NM_012301.4 ENSP00000346151.4 Q86UL8-1

Frequencies

GnomAD3 genomes
AF:
0.327
AC:
49520
AN:
151548
Hom.:
8539
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.427
Gnomad AMI
AF:
0.110
Gnomad AMR
AF:
0.257
Gnomad ASJ
AF:
0.313
Gnomad EAS
AF:
0.227
Gnomad SAS
AF:
0.295
Gnomad FIN
AF:
0.283
Gnomad MID
AF:
0.399
Gnomad NFE
AF:
0.302
Gnomad OTH
AF:
0.317
GnomAD2 exomes
AF:
0.288
AC:
71929
AN:
249956
AF XY:
0.291
show subpopulations
Gnomad AFR exome
AF:
0.433
Gnomad AMR exome
AF:
0.193
Gnomad ASJ exome
AF:
0.308
Gnomad EAS exome
AF:
0.237
Gnomad FIN exome
AF:
0.284
Gnomad NFE exome
AF:
0.298
Gnomad OTH exome
AF:
0.304
GnomAD4 exome
AF:
0.303
AC:
442211
AN:
1458446
Hom.:
68322
Cov.:
33
AF XY:
0.303
AC XY:
219956
AN XY:
725486
show subpopulations
African (AFR)
AF:
0.437
AC:
14571
AN:
33348
American (AMR)
AF:
0.203
AC:
9061
AN:
44550
Ashkenazi Jewish (ASJ)
AF:
0.309
AC:
8037
AN:
26044
East Asian (EAS)
AF:
0.239
AC:
9472
AN:
39650
South Asian (SAS)
AF:
0.301
AC:
25863
AN:
85836
European-Finnish (FIN)
AF:
0.289
AC:
15410
AN:
53342
Middle Eastern (MID)
AF:
0.385
AC:
2214
AN:
5754
European-Non Finnish (NFE)
AF:
0.305
AC:
338642
AN:
1109682
Other (OTH)
AF:
0.314
AC:
18941
AN:
60240
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
14100
28199
42299
56398
70498
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11156
22312
33468
44624
55780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.327
AC:
49586
AN:
151666
Hom.:
8564
Cov.:
32
AF XY:
0.324
AC XY:
23974
AN XY:
74082
show subpopulations
African (AFR)
AF:
0.427
AC:
17661
AN:
41366
American (AMR)
AF:
0.257
AC:
3897
AN:
15188
Ashkenazi Jewish (ASJ)
AF:
0.313
AC:
1085
AN:
3466
East Asian (EAS)
AF:
0.227
AC:
1163
AN:
5128
South Asian (SAS)
AF:
0.294
AC:
1418
AN:
4816
European-Finnish (FIN)
AF:
0.283
AC:
2973
AN:
10508
Middle Eastern (MID)
AF:
0.391
AC:
115
AN:
294
European-Non Finnish (NFE)
AF:
0.302
AC:
20492
AN:
67878
Other (OTH)
AF:
0.323
AC:
682
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1685
3370
5056
6741
8426
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
484
968
1452
1936
2420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.310
Hom.:
12366
Bravo
AF:
0.329
Asia WGS
AF:
0.290
AC:
1009
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Oct 25, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 20, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Jul 15, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 41% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 38. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.44
CADD
Benign
13
DANN
Benign
0.81
PhyloP100
1.7
PromoterAI
-0.045
Neutral
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3735442; hg19: chr7-78119109; COSMIC: COSV62640934; COSMIC: COSV62640934; API